Evidence map›Paper›PMID 26672891›Full record

ReviewGastrointestinal tumors2015

Hamartomatous Tumors in the Gastrointestinal Tract.

Estell Cauchin, Yan Touchefeu, Tamar Matysiak-Budnik

Open access · goldAbstract readReview
In one paragraph

Review in Gastrointestinal tumors, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. A systematic review of symptomatic hamartomas of the jejunum and ileum.Annals of the Royal College of Surgeons of England · 2022
    Pooled it
  2. Article
  3. Endoscopic submucosal dissection in the management of bleeding duodenal tumors refractory to conventional therapy.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Rare Isolated Duodenal Hamartomatous Polyp in an Elderly Patient.The American journal of case reports · 2023
    Article
  10. Article
  11. Article
  12. JUVENILE POLYP IN ADULTS.Acta clinica Croatica · 2022
    Article
  13. Review
  14. Article
  15. [LKB1 regulates epithelial-mesenchymal transition in Peutz-Jeghers hamartoma and intestinal epithelial cells].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Estell CauchinIMAD, Hepato-Gastroenterology and Digestive Oncology, Hôtel Dieu/CHU de Nantes, Nantes, France.
Yan TouchefeuIMAD, Hepato-Gastroenterology and Digestive Oncology, Hôtel Dieu/CHU de Nantes, Nantes, France.
Tamar Matysiak-BudnikIMAD, Hepato-Gastroenterology and Digestive Oncology, Hôtel Dieu/CHU de Nantes, Nantes, France.
Centre Hospitalier Universitaire de Nantes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDigestive hamartomatous polyps are a rare entity. They may be sporadic (solitary Peutz-Jeghers polyp or solitary juvenile polyp) or reveal genetic predisposition like Peutz-Jeghers syndrome, juvenile polyposis or Cowden disease. SUMMARY: Diagnosis is based on personal and family history and on clinical data including physical signs (in particular dermatological), endoscopic findings (the number of polyps) and histological features of the polyps. The risk of complications and of digestive and extra-digestive cancers may be high, especially in case of genetic predisposition syndromes, and requires multidisciplinary management of the patients (oncogenetic counseling, gastroenterologist, pathologist, dermatologist, gynecologist and endocrinologist). Endoscopic evaluation is very helpful to establish the current situation, to perform polypectomy and to allow for good histological examination of the polyps, whose degeneration has been exceptionally described. The recent development of new molecular techniques (next-generation DNA sequencing) allows for rapid multiple gene sequencing and facilitates diagnosis. KEY MESSAGE: Discovery of a hamartomatous polyp requires a rigorous work-up which should be performed by a multidisciplinary team, including a genetic oncologist, experienced in this pathology. PRACTICAL IMPLICATIONS: The diagnostic procedure in hamartomatous polyps should be based on the number of polyps identified during endoscopy (solitary versus multiple) and on their histological characteristics. The clinical examination must search for mucosal and skin lesions. If a polyposis syndrome is identified, oncogenetic consultation is necessary in order to define screening modalities for family members, aiming at preventing cancer development. Endoscopic resection (polypectomy) of the lesions may prevent complications like bleeding and degeneration and also diminish the risk of surgery and subsequent short bowel syndrome.

Indexed as

Cowden syndromeGenetic predispositionHamartomatous polyposisHamartomatous polypsJuvenile polyposisPeutz-Jeghers syndrome

Identifiers

PMID26672891
PMCPMC4668787
OpenAlexW1898346180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.